| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.6B | — | $1.6B | — | -1.5% |
| Op. Income | $152M | — | $165M | — | -8.0% |
| Gross Margin | 24.8% | — | 25.3% | — | -0.5pp |
| Net Margin | 6.5% | — | 7.1% | — | -0.6pp |
| EPS (Diluted) | $8.59 | — | $9.63 | — | -10.8% |
| Free Cash Flow | $147M | — | $185M | — | -20.5% |
| Item | Amount |
|---|---|
| REVENUE | $1.6B |
| Cost of Revenue | $1.2B |
| GROSS PROFIT | $398M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $230M |
| Other Expenses | $17M |
| Operating Expenses | $246M |
| Cost & Expenses | $1.5B |
| OPERATING INCOME | $152M |
| Interest Income | $6M |
| Interest Expense | $15M |
| Other Income/Expenses | -$12M |
| INCOME BEFORE TAX | $140M |
| Income Tax Expense | $36M |
| NET INCOME | $104M |
| D&A | $44M |
| EBIT | $154M |
| EBITDA | $198M |
| EPS | $9 |
| EPS Diluted | $9 |
| Item | Amount |
|---|---|
| REVENUE | $1.6B |
| Cost of Revenue | $1.2B |
| GROSS PROFIT | $398M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $230M |
| Other Expenses | $17M |
| Operating Expenses | $246M |
| Cost & Expenses | $1.5B |
| OPERATING INCOME | $152M |
| Interest Income | $6M |
| Interest Expense | $15M |
| Other Income/Expenses | -$12M |
| INCOME BEFORE TAX | $140M |
| Income Tax Expense | $36M |
| NET INCOME | $104M |
| D&A | $44M |
| EBIT | $154M |
| EBITDA | $198M |
| EPS | $9 |
| EPS Diluted | $9 |
| Item | Amount |
|---|---|
| Net Income | $104M |
| Depreciation & Amortization | $44M |
| Stock-Based Compensation | $10M |
| Deferred Income Tax | $11M |
| Other Non-Cash Items | $10M |
| Change in Working Capital | -$418.0K |
| OPERATING CASH FLOW | $178M |
| Capital Expenditure | -$31M |
| Acquisitions (Net) | -$18M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $3M |
| NET CASH FROM INVESTING | -$46M |
| Net Debt Issuance | -$15M |
| Common Stock Repurchased | -$3M |
| Common Dividends Paid | -$14M |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$31M |
| FREE CASH FLOW | $147M |
| Net Change in Cash | $112M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $310M |
| Short-Term Investments | $0 |
| Net Receivables | $294M |
| Inventory | $383M |
| Other Current Assets | $12M |
| TOTAL CURRENT ASSETS | $998M |
| PP&E (Net) | $241M |
| Goodwill | $215M |
| Intangible Assets | $145M |
| Long-Term Investments | $0 |
| Tax Assets | $1M |
| Other Non-Current Assets | $6M |
| TOTAL NON-CURRENT ASSETS | $609M |
| TOTAL ASSETS | $1.6B |
| Account Payables | $125M |
| Short-Term Debt | $21M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $26M |
| TOTAL CURRENT LIABILITIES | $218M |
| Long-Term Debt | $191M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $24M |
| Other Non-Current Liabilities | $16M |
| TOTAL NON-CURRENT LIABILITIES | $240M |
| TOTAL LIABILITIES | $458M |
| Common Stock | $1M |
| Additional Paid-In Capital | $155M |
| Retained Earnings | $1.0B |
| Treasury Stock | -$5M |
| Accum. Other Comp. Income | -$49M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.1B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.1B |
| TOTAL LIABILITIES & EQUITY | $1.6B |
| Total Debt | $220M |
| Net Debt | -$89M |
